For people seeking a non-surgical path to meaningful weight loss, the gastric balloon has emerged as a compelling option — but not everyone is automatically a candidate. Understanding the qualifying criteria can help individuals make informed decisions about their health journey.
What Is a Gastric Balloon Trial?
A gastric balloon trial refers to the process of evaluating whether a patient is a suitable candidate for intragastric balloon therapy and, if approved, undergoing the treatment as part of a structured weight management program. Unlike bariatric surgery, the intragastric balloon is a minimally invasive intervention that does not require any surgical incisions. Instead, a soft, deflated balloon is placed into the stomach endoscopically and then filled with saline, reducing the available stomach volume and promoting a feeling of fullness with smaller food portions.
The procedure is designed to be temporary, typically remaining in place for around six months, and is always paired with behavioral counseling, dietary support, and lifestyle modifications. This comprehensive approach is what distinguishes the gastric balloon from standalone dietary interventions and positions it as a medically supervised weight loss strategy.
The BMI Threshold: Who Falls Within the Range?
Body mass index plays a central role in determining whether someone qualifies for a gastric balloon trial. The ORBERA intragastric balloon, which received U.S. Food and Drug Administration approval as a non-surgical obesity treatment, is approved for patients with a BMI ranging from 30 to 40 (source). This range is significant because it targets a segment of the population that often falls through the cracks of conventional treatment pathways.
Bariatric surgery, by contrast, typically requires a BMI above 35 with accompanying health conditions, or a BMI above 40 for patients with severe obesity (source). Individuals with a BMI between 30 and 35 who do not have qualifying comorbidities are generally not candidates for surgical intervention, yet they still carry meaningful health risks associated with excess weight. The gastric balloon was specifically developed to address this treatment gap, offering a medically recognized option for those who do not meet the threshold for surgery but still need support beyond diet and exercise alone.
Obesity-Related Health Conditions and Candidacy
Beyond BMI numbers alone, a patient’s broader health profile plays an important role in determining eligibility. Common obesity-related conditions that may influence candidacy include hypertension, high cholesterol, cardiovascular disease, type 2 diabetes, obstructive sleep apnea, and metabolic dysfunction-associated steatotic liver disease (source). The presence of one or more of these conditions can strengthen the medical rationale for pursuing gastric balloon therapy, as weight reduction in such patients often leads to meaningful improvements in overall health outcomes.
Healthcare providers evaluate each patient individually, weighing the potential benefits of weight loss against any factors that could complicate the procedure or recovery. A thorough pre-treatment assessment typically involves reviewing a patient’s medical history, current medications, and any prior attempts at weight management.
Age, Weight History, and the Broader Qualification Picture
Candidacy isn’t determined by a single snapshot in time — providers also look closely at a patient’s weight history and life stage. Most programs set a general age range, often adults between roughly 18 and 65, since younger patients may still be developing physically and older patients may face different risk-benefit calculations tied to age-related health changes. Just as important is documenting previous weight-loss efforts: providers typically want to see that a patient has already tried structured approaches like supervised diets, exercise programs, or behavioral therapy without achieving lasting results.
This history isn’t used to disqualify someone, but rather to build a clearer clinical picture of why a more structured, device-assisted intervention makes sense for that individual. It also helps the care team anticipate which lifestyle changes may be hardest for a given patient to sustain, allowing them to tailor the counseling and support that accompanies the balloon to that person’s specific patterns and challenges.
When the Gastric Balloon Bridges the Gap Before Surgery
The gastric balloon is not exclusively reserved for patients who want to avoid surgery altogether. In some cases, it serves as a preparatory step for individuals whose BMI is extremely high and who may benefit from losing a portion of their excess weight before undergoing a more extensive bariatric procedure (source). Reducing body weight ahead of surgery can lower associated risks and improve surgical outcomes, making the balloon a useful tool across a broader spectrum of patients.
This dual role further illustrates how the intragastric balloon fits into a continuum of obesity treatment rather than functioning as a single isolated solution. The FDA approval of ORBERA added another nonsurgical option for obesity treatment, expanding the range of approaches available alongside lifestyle counseling, medications, other endoscopic therapies, and bariatric surgery (source).
Contraindications and Factors That May Disqualify Candidates
While the gastric balloon trial opens doors for many patients, it is not appropriate for everyone. Certain medical conditions, anatomical considerations, and psychological factors may disqualify a prospective candidate. Prior gastrointestinal surgeries, active stomach ulcers, certain inflammatory bowel conditions, or a history of difficulty with endoscopic procedures can all affect eligibility. Patients with significant psychiatric conditions or a history of substance use that has not been addressed may also be screened out during the evaluation process.
Additionally, pregnancy or plans to become pregnant during the treatment period would exclude a patient from consideration. Medical providers conduct detailed screening to ensure that only those who are likely to benefit safely from the procedure move forward. This careful patient selection is a key reason why gastric balloon therapy maintains a strong overall safety profile as a minimally invasive weight loss intervention (source).
The Role of Commitment in Qualifying
Medical eligibility alone does not guarantee acceptance into a gastric balloon program. Because the procedure is most effective when paired with lifestyle changes, many providers look for evidence that a patient is genuinely prepared to engage with dietary coaching and behavioral support throughout the treatment period. Candidates who demonstrate motivation, realistic expectations, and a willingness to commit to follow-up care tend to be viewed as the strongest prospects for successful outcomes.
Clinical trial data has shown that the device produces greater weight loss results compared to diet and exercise alone, but those advantages are maximized when patients actively participate in the comprehensive support program that accompanies the balloon placement (source). The gastric balloon, therefore, is both a medical device and a behavioral commitment.
Learn More About Gastric Balloon Trials
The gastric balloon trial represents a meaningful advancement in non-surgical obesity treatment, filling a genuine gap between lifestyle interventions and bariatric surgery. For individuals with a BMI in the 30 to 40 range, especially those managing related health conditions, it offers a medically supported path toward meaningful weight loss.
Whether someone is looking to improve their overall health, reduce obesity-related risks, or prepare for a future surgical procedure, understanding the qualification criteria is the first step. Speaking with a qualified bariatric or weight management specialist can help determine whether the gastric balloon is the right fit for an individual’s specific health profile and long-term goals.